Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 283

1.

Test stewardship, frequency and fidelity: Impact on reported hospital-onset Clostridioides difficile.

Fleming MS, Hess O, Albert HL, Styslinger E, Doll M, Nguyen HJ, McAulay-Kidd S, Hemphill RR, Srivastava T, Cooper KD, Stevens MP, Bearman G.

Infect Control Hosp Epidemiol. 2019 Jun;40(6):710-712. doi: 10.1017/ice.2019.63. Epub 2019 Apr 22.

PMID:
31006411
2.

Validity and Reliability of the Polar A300's Fitness Test Feature to Predict VO2max.

Cooper KD, Shafer AB.

Int J Exerc Sci. 2019 Mar 1;12(4):393-401. eCollection 2019.

3.

Combining mechanism-based prediction with patient-based profiling for psoriasis metabolomics biomarker discovery.

Wang Q, McCormick TS, Ward NL, Cooper KD, Conic R, Xu R.

AMIA Annu Symp Proc. 2018 Apr 16;2017:1734-1743. eCollection 2017.

4.

Acute pustular eruption following a Jarisch-Herxheimer reaction in the treatment of syphilis.

Giesey RL, Delost GR, Sharma TR, Cooper KD.

JAAD Case Rep. 2018 Mar 6;4(3):259-261. doi: 10.1016/j.jdcr.2017.09.017. eCollection 2018 Apr. No abstract available.

5.

An analysis of gene expression data involving examination of signaling pathways activation reveals new insights into the mechanism of action of minoxidil topical foam in men with androgenetic alopecia.

Stamatas GN, Wu J, Pappas A, Mirmirani P, McCormick TS, Cooper KD, Consolo M, Schastnaya J, Ozerov IV, Aliper A, Zhavoronkov A.

Cell Cycle. 2017;16(17):1578-1584. doi: 10.1080/15384101.2017.1327492. Epub 2017 Jun 8.

6.

Oral Vitamin D Rapidly Attenuates Inflammation from Sunburn: An Interventional Study.

Scott JF, Das LM, Ahsanuddin S, Qiu Y, Binko AM, Traylor ZP, Debanne SM, Cooper KD, Boxer R, Lu KQ.

J Invest Dermatol. 2017 Oct;137(10):2078-2086. doi: 10.1016/j.jid.2017.04.040. Epub 2017 May 30.

7.

The ratio of HLA-DR and VNN2+ expression on CD14+ myeloid derived suppressor cells can distinguish glioblastoma from radiation necrosis patients.

Soler DC, Young AB, Cooper KD, Kerstetter-Fogle A, Barnholtz-Sloan JS, Gittleman H, McCormick TS, Sloan AE.

J Neurooncol. 2017 Aug;134(1):189-196. doi: 10.1007/s11060-017-2508-7. Epub 2017 May 27.

PMID:
28551851
8.

Phenotypical analysis of ectoenzymes CD39/CD73 and adenosine receptor 2A in CD4+ CD25high Foxp3+ regulatory T-cells in psoriasis.

Han L, Sugiyama H, Zhang Q, Yan K, Fang X, McCormick TS, Cooper KD, Huang Q.

Australas J Dermatol. 2018 Feb;59(1):e31-e38. doi: 10.1111/ajd.12561. Epub 2017 Mar 15.

9.

Evaluation of O6-Benzylguanine-Potentiated Topical Carmustine for Mycosis Fungoides: A Phase 1-2 Clinical Trial.

Tacastacas JD, Chan DV, Carlson S, Gerson SL, Dowlati A, Fu P, Lu K, Groft S, Rosenjack J, Honda K, McCormick TS, Cooper KD.

JAMA Dermatol. 2017 May 1;153(5):413-420. doi: 10.1001/jamadermatol.2016.5793. Erratum in: JAMA Dermatol. 2017 May 1;153(5):479.

10.

Does imiquimod pretreatment optimize 308-nm excimer laser (UVB) therapy in psoriasis patients?

Tacastacas JD, Oyetakin-White P, Soler DC, Young A, Groft S, Honda K, Cooper KD, McCormick TS.

Photodermatol Photoimmunol Photomed. 2017 Jul;33(4):193-202. doi: 10.1111/phpp.12299. Epub 2017 Apr 20.

11.

Overexpression of AQP3 and AQP10 in the skin exacerbates psoriasiform acanthosis.

Soler DC, Young AE, Griffith AD, Fu PF, Cooper KD, McCormick TS, Popkin DL.

Exp Dermatol. 2017 Oct;26(10):949-951. doi: 10.1111/exd.13307. Epub 2017 Apr 21.

12.

From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis.

Armstrong AW, Siegel MP, Bagel J, Boh EE, Buell M, Cooper KD, Callis Duffin K, Eichenfield LF, Garg A, Gelfand JM, Gottlieb AB, Koo JY, Korman NJ, Krueger GG, Lebwohl MG, Leonardi CL, Mandelin AM, Menter MA, Merola JF, Pariser DM, Prussick RB, Ryan C, Shah KN, Weinberg JM, Williams MO, Wu JJ, Yamauchi PS, Van Voorhees AS.

J Am Acad Dermatol. 2017 Feb;76(2):290-298. doi: 10.1016/j.jaad.2016.10.017. Epub 2016 Nov 28. Review.

13.

Feasibility of carotid artery PET/MRI in psoriasis patients.

Rajiah P, Hojjati M, Lu Z, Kosaraju V, Partovi S, O'Donnell JK, Longenecker C, McComsey GA, Golden JB, Muakkassa F, Santilli S, McCormick TS, Cooper KD, Korman NJ.

Am J Nucl Med Mol Imaging. 2016 Aug 20;6(4):223-33. eCollection 2016.

14.

Visualization of atherosclerosis as detected by coronary artery calcium and carotid intima-media thickness reveals significant atherosclerosis in a cross-sectional study of psoriasis patients in a tertiary care center.

Santilli S, Kast DR, Grozdev I, Cao L, Feig RL, Golden JB, Debanne SM, Gilkeson RC, Orringer CE, McCormick TS, Ward NL, Cooper KD, Korman NJ.

J Transl Med. 2016 Jul 22;14(1):217. doi: 10.1186/s12967-016-0947-0.

15.

Activated T cells exhibit increased uptake of silicon phthalocyanine Pc 4 and increased susceptibility to Pc 4-photodynamic therapy-mediated cell death.

Soler DC, Ohtola J, Sugiyama H, Rodriguez ME, Han L, Oleinick NL, Lam M, Baron ED, Cooper KD, McCormick TS.

Photochem Photobiol Sci. 2016 Jun 8;15(6):822-31. doi: 10.1039/c6pp00058d. Epub 2016 May 10.

16.

The Response of microRNAs to Solar UVR in Skin-Resident Melanocytes Differs between Melanoma Patients and Healthy Persons.

Sha J, Gastman BR, Morris N, Mesinkovska NA, Baron ED, Cooper KD, McCormick T, Arbesman J, Harter ML.

PLoS One. 2016 May 5;11(5):e0154915. doi: 10.1371/journal.pone.0154915. eCollection 2016.

17.

Parotid melanoma of unknown primary.

Scott JF, Thompson CL, Vyas R, Honda K, Zender C, Rezaee R, Lavertu P, Koon H, Cooper KD, Gerstenblith MR.

J Cancer Res Clin Oncol. 2016 Jul;142(7):1529-37. doi: 10.1007/s00432-016-2156-x. Epub 2016 Apr 13.

PMID:
27075178
18.

Aggressive CD8(+) epidermotropic cutaneous T-cell lymphoma associated with homozygous mutation in SAMHD1.

Merati M, Buethe DJ, Cooper KD, Honda KS, Wang H, Gerstenblith MR.

JAAD Case Rep. 2015 Jun 25;1(4):227-9. doi: 10.1016/j.jdcr.2015.05.003. eCollection 2015 Jul. No abstract available.

19.

Case report of individual with cutaneous immunodeficiency and novel 1p36 duplication.

Hatter AD, Soler DC, Curtis C, Cooper KD, McCormick TS.

Appl Clin Genet. 2016 Jan 13;9:1-4. doi: 10.2147/TACG.S90713. eCollection 2016.

20.

Increased, but Functionally Impaired, CD14(+) HLA-DR(-/low) Myeloid-Derived Suppressor Cells in Psoriasis: A Mechanism of Dysregulated T Cells.

Soler DC, Young AB, Fiessinger L, Galimberti F, Debanne S, Groft S, McCormick TS, Cooper KD.

J Invest Dermatol. 2016 Apr;136(4):798-808. doi: 10.1016/j.jid.2015.12.036. Epub 2016 Jan 22.

21.

Resident Rounds: Part III--Case Report: Metastatic Multiple Myeloma.

Scott JF, Merati M, Honda K, Cooper KD, Reichert B.

J Drugs Dermatol. 2015 Dec;14(12):1485-6.

PMID:
26741539
22.

A systematic review and meta-analysis of animal-type melanoma.

Vyas R, Keller JJ, Honda K, Cooper KD, Gerstenblith MR.

J Am Acad Dermatol. 2015 Dec;73(6):1031-9. doi: 10.1016/j.jaad.2015.08.016. Epub 2015 Sep 26. Review.

PMID:
26412164
23.

Genetic vs Environmental Factors That Correlate With Rosacea: A Cohort-Based Survey of Twins.

Aldrich N, Gerstenblith M, Fu P, Tuttle MS, Varma P, Gotow E, Cooper KD, Mann M, Popkin DL.

JAMA Dermatol. 2015 Nov;151(11):1213-9. doi: 10.1001/jamadermatol.2015.2230.

PMID:
26307938
24.

Chronic Psoriatic Skin Inflammation Leads to Increased Monocyte Adhesion and Aggregation.

Golden JB, Groft SG, Squeri MV, Debanne SM, Ward NL, McCormick TS, Cooper KD.

J Immunol. 2015 Sep 1;195(5):2006-18. doi: 10.4049/jimmunol.1402307. Epub 2015 Jul 29.

25.

A Community-Academic Partnership to Increase Pap Testing in Appalachian Kentucky.

Collins T, Stradtman LR, Vanderpool RC, Neace DR, Cooper KD.

Am J Prev Med. 2015 Aug;49(2):324-30. doi: 10.1016/j.amepre.2015.04.028.

26.

Novel Somatic Mutation in LEMD3 Splice Site Results in Buschke-Ollendorff Syndrome with Polyostotic Melorheostosis and Osteopoikilosis.

Gutierrez D, Cooper KD, Mitchell AL, Cohn HI.

Pediatr Dermatol. 2015 Sep-Oct;32(5):e219-20. doi: 10.1111/pde.12634. Epub 2015 Jul 2.

PMID:
26135202
27.

The key role of aquaporin 3 and aquaporin 10 in the pathogenesis of pompholyx.

Soler DC, Bai X, Ortega L, Pethukova T, Nedorost ST, Popkin DL, Cooper KD, McCormick TS.

Med Hypotheses. 2015 May;84(5):498-503. doi: 10.1016/j.mehy.2015.02.006. Epub 2015 Feb 11.

28.

What is your diagnosis? Cutaneous B-cell lymphoma.

Carlson SW, Aneja S, Honda K, Cooper KD.

Cutis. 2014 Nov;94(5):217, quiz 249-51. No abstract available.

PMID:
25474456
29.

Does poor sleep quality affect skin ageing?

Oyetakin-White P, Suggs A, Koo B, Matsui MS, Yarosh D, Cooper KD, Baron ED.

Clin Exp Dermatol. 2015 Jan;40(1):17-22. doi: 10.1111/ced.12455. Epub 2014 Sep 30.

PMID:
25266053
30.

Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches.

Sidbury R, Tom WL, Bergman JN, Cooper KD, Silverman RA, Berger TG, Chamlin SL, Cohen DE, Cordoro KM, Davis DM, Feldman SR, Hanifin JM, Krol A, Margolis DJ, Paller AS, Schwarzenberger K, Simpson EL, Williams HC, Elmets CA, Block J, Harrod CG, Smith Begolka W, Eichenfield LF.

J Am Acad Dermatol. 2014 Dec;71(6):1218-33. doi: 10.1016/j.jaad.2014.08.038. Epub 2014 Sep 26.

31.

Hyper-inflammation and skin destruction mediated by rosiglitazone activation of macrophages in IL-6 deficiency.

Das LM, Rosenjack J, Au L, Galle PS, Hansen MB, Cathcart MK, McCormick TS, Cooper KD, Silverstein RL, Lu KQ.

J Invest Dermatol. 2015 Feb;135(2):389-399. doi: 10.1038/jid.2014.375. Epub 2014 Sep 3.

32.

Update on primary mucosal melanoma.

Tacastacas JD, Bray J, Cohen YK, Arbesman J, Kim J, Koon HB, Honda K, Cooper KD, Gerstenblith MR.

J Am Acad Dermatol. 2014 Aug;71(2):366-75. doi: 10.1016/j.jaad.2014.03.031. Epub 2014 May 6. Review.

PMID:
24815565
33.

Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies.

Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, Bergman JN, Chamlin SL, Cohen DE, Cooper KD, Cordoro KM, Davis DM, Feldman SR, Hanifin JM, Margolis DJ, Silverman RA, Simpson EL, Williams HC, Elmets CA, Block J, Harrod CG, Smith Begolka W, Sidbury R.

J Am Acad Dermatol. 2014 Jul;71(1):116-32. doi: 10.1016/j.jaad.2014.03.023. Epub 2014 May 9.

34.

Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.

Sidbury R, Davis DM, Cohen DE, Cordoro KM, Berger TG, Bergman JN, Chamlin SL, Cooper KD, Feldman SR, Hanifin JM, Krol A, Margolis DJ, Paller AS, Schwarzenberger K, Silverman RA, Simpson EL, Tom WL, Williams HC, Elmets CA, Block J, Harrod CG, Begolka WS, Eichenfield LF; American Academy of Dermatology.

J Am Acad Dermatol. 2014 Aug;71(2):327-49. doi: 10.1016/j.jaad.2014.03.030. Epub 2014 May 9.

35.

Cutaneous Rosai-Dorfman disease successfully treated with low-dose methotrexate.

Sun NZ, Galvin J, Cooper KD.

JAMA Dermatol. 2014 Jul;150(7):787-8. doi: 10.1001/jamadermatol.2013.8679. No abstract available.

PMID:
24789266
36.

Silicon phthalocyanine 4 phototoxicity in Trichophyton rubrum.

Lam M, Dimaano ML, Oyetakin-White P, Retuerto MA, Chandra J, Mukherjee PK, Ghannoum MA, Cooper KD, Baron ED.

Antimicrob Agents Chemother. 2014 Jun;58(6):3029-34. doi: 10.1128/AAC.01448-13. Epub 2014 Mar 10.

37.

Psoriasis and cardiovascular risk factors: increased serum myeloperoxidase and corresponding immunocellular overexpression by Cd11b(+) CD68(+) macrophages in skin lesions.

Cao LY, Soler DC, Debanne SM, Grozdev I, Rodriguez ME, Feig RL, Carman TL, Gilkeson RC, Orringer CE, Kern EF, McCormick TS, Cooper KD, Korman NJ.

Am J Transl Res. 2013 Dec 1;6(1):16-27. eCollection 2013.

38.

Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.

Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL, Berger TG, Bergman JN, Cohen DE, Cooper KD, Cordoro KM, Davis DM, Krol A, Margolis DJ, Paller AS, Schwarzenberger K, Silverman RA, Williams HC, Elmets CA, Block J, Harrod CG, Smith Begolka W, Sidbury R.

J Am Acad Dermatol. 2014 Feb;70(2):338-51. doi: 10.1016/j.jaad.2013.10.010. Epub 2013 Nov 27. Review.

39.

Psoriasis patients exhibit impairment of the high potency CCR5(+) T regulatory cell subset.

Soler DC, Sugiyama H, Young AB, Massari JV, McCormick TS, Cooper KD.

Clin Immunol. 2013 Oct;149(1):111-8. doi: 10.1016/j.clim.2013.06.007. Epub 2013 Jul 6.

40.

Prognosis of patients with transected melanomas.

Martires KJ, Nandi T, Honda K, Cooper KD, Bordeaux JS.

Dermatol Surg. 2013 Apr;39(4):605-15. doi: 10.1111/dsu.12124. Epub 2013 Feb 4.

PMID:
23379583
41.

Computerized interactive educational tools used to improve use of sun-protective clothing and sunscreen: a randomized controlled study.

Aneja S, Brimhall AK, Aneja S, Kast DR, Carlson D, Cooper KD, Bordeaux JS.

Arch Dermatol. 2012 Nov;148(11):1325-7. doi: 10.1001/archdermatol.2012.2603. No abstract available.

PMID:
23165847
42.

Single administration of lesion-limited high-dose (TURBO) ultraviolet B using the excimer laser: clinical clearing in association with apoptosis of epidermal and dermal T cell subsets in psoriasis.

Kagen M, Cao LY, Oyetakin-White P, Tacastacas JD, Yan C, McCormick TS, Cooper KD.

Photodermatol Photoimmunol Photomed. 2012 Dec;28(6):293-8. doi: 10.1111/j.1600-0781.2012.00692.x.

PMID:
23126290
43.

Cutaneous penetration of the topically applied photosensitizer Pc 4 as detected by intravital 2-photon laser scanning microscopy.

Huang AY, Myers JT, Barkauskas D, Howell SJ, Oleinick NL, McCormick TS, Cooper KD, Baron ED, Lam M.

Photodiagnosis Photodyn Ther. 2012 Sep;9(3):225-31. doi: 10.1016/j.pdpdt.2012.01.007. Epub 2012 Feb 23.

44.

Improvement in Patient Performance of Skin Self-examinations After Intervention With Interactive Education and Telecommunication Reminders: A Randomized Controlled Study.

Aneja S, Brimhall AK, Kast DR, Aneja S, Carlson D, Cooper KD, Bordeaux JS.

Arch Dermatol. 2012 Nov;148(11):1266-72. doi: 10.1001/archdermatol.2012.2480.

PMID:
22911048
45.

A Core Curriculum for Dermatology Nurse Practitioners: Using Delphi Technique.

Bobonich M, Cooper KD.

J Dermatol Nurses Assoc. 2012 Mar;4(2):108-120. No abstract available.

46.

Chronic skin-specific inflammation promotes vascular inflammation and thrombosis.

Wang Y, Gao H, Loyd CM, Fu W, Diaconu D, Liu S, Cooper KD, McCormick TS, Simon DI, Ward NL.

J Invest Dermatol. 2012 Aug;132(8):2067-75. doi: 10.1038/jid.2012.112. Epub 2012 May 10.

47.

Regulation generation: the suppressive functions of human regulatory T cells.

Goodman WA, Cooper KD, McCormick TS.

Crit Rev Immunol. 2012;32(1):65-79. Review.

48.

Phase I clinical trial of O6-benzylguanine and topical carmustine in the treatment of cutaneous T-cell lymphoma, mycosis fungoides type.

Apisarnthanarax N, Wood GS, Stevens SR, Carlson S, Chan DV, Liu L, Szabo SK, Fu P, Gilliam AC, Gerson SL, Remick SC, Cooper KD.

Arch Dermatol. 2012 May;148(5):613-20. doi: 10.1001/archdermatol.2011.2797.

49.

Physical and mental impact of psoriasis severity as measured by the compact Short Form-12 Health Survey (SF-12) quality of life tool.

Grozdev I, Kast D, Cao L, Carlson D, Pujari P, Schmotzer B, Babineau D, Kern E, McCormick T, Cooper KD, Korman NJ.

J Invest Dermatol. 2012 Apr;132(4):1111-6. doi: 10.1038/jid.2011.427. Epub 2011 Dec 29.

50.

Radiation therapy in the management of unilesional primary cutaneous T-cell lymphomas.

Chan DV, Aneja S, Honda K, Carlson S, Yao M, Katcher J, Cooper KD.

Br J Dermatol. 2012 May;166(5):1134-7. doi: 10.1111/j.1365-2133.2011.10728.x. Epub 2012 Mar 2. No abstract available.

PMID:
22059744

Supplemental Content

Loading ...
Support Center